Using Surface Immunogenic Protein as a Carrier Protein to Elicit Protective Antibody to Multiple Serotypes for Candidate Group B Streptococcal Glycan Conjugate Vaccines

Using Surface Immunogenic Protein as a Carrier Protein to Elicit Protective Antibody to Multiple Serotypes for Candidate Group B Streptococcal Glycan Conjugate Vaccines

<i>Group B Streptococcus</i> (GBS) is a life-threatening opportunistic pathogen, particularly in pregnant women, infants, and the elderly. Currently, maternal vaccination is considered the most viable long-term option for preventing GBS mother-to-infant infection, and two polysaccharide...

Full description

Bibliographic Details
Main Authors: Huiqi Duan, Wenhua Huang, Qingyu Lv, Peng Liu, Qian Li, Decong Kong, Xuyang Sun, Xinran Zhang, Yongqiang Jiang, Shaolong Chen
Format: Article
Language:English
Published: MDPI AG 2024-05-01
Series:Vaccines
Subjects:
<i>Group B Streptococcus</i> (GBS)
surface immunogenic protein (Sip)
glycan conjugate vaccine
serotype-independent protection
Online Access:https://www.mdpi.com/2076-393X/12/6/573

Internet

https://www.mdpi.com/2076-393X/12/6/573

Similar Items